AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 2,595.00
+130.00 (5.27%)
At close: Sep 3, 2026
AriBioLab Market Cap
AriBioLab has a market cap or net worth of 73.82 billion as of September 4, 2026. Its market cap has decreased by -0.45% in one year.
Market Cap
73.82B
Enterprise Value
64.36B
Revenue
173.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
2,595.00
ChartMarket Cap Chart
Since October 22, 2021, AriBioLab's market cap has decreased from 343.58B to 73.82B, a decrease of -78.52%. That is a compound annual growth rate of -27.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 73.82B | -2.74% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | 343.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EyeGene | 82.31B |
| BIO-FD&C | 78.70B |
| SunBio,Inc. | 75.48B |
| CTCBIO | 74.36B |
| IMGT Co.,Ltd. | 71.33B |
| Psomagen | 69.15B |
| ADBiotech | 68.59B |
| Naturalendo Tech | 67.88B |